Selected research
Industry Research
Adult Antipyretics Industry Research Report 2026
Market perspective
The global Adult Antipyretics market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Adult Antipyretics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Adult Antipyretics is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Adult Antipyretics is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Adult Antipyretics include Anqiu Lu'an, Atabay, Farmson, Granules Biocause, Granules India, IOLCP, Mallinckrodt, Novacyl and SKPL, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Adult Antipyretics market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Adult Antipyretics Market by Company
Anqiu Lu'an
Atabay
Farmson
Granules Biocause
Granules India
IOLCP
Mallinckrodt
Novacyl
SKPL
Strides Shasun
Temad
Anhui BBCA Likang
Anhui Fubore
Changshu Huagang
Hebei Jiheng
Xinhua Pharmaceutical
Zhejiang Kangle
Adult Antipyretics Segment by Type
Acetaminophen
Ibuprofen
Other
Adult Antipyretics Segment by Application
Online Sales
Offline Sales
Adult Antipyretics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Adult Antipyretics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Adult Antipyretics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Adult Antipyretics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Adult Antipyretics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Adult Antipyretics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Adult Antipyretics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Acetaminophen
- Ibuprofen
- Other
Applications
- Online Sales
- Offline Sales
Companies covered
- Anqiu Lu'an
- Atabay
- Farmson
- Granules Biocause
- Granules India
- IOLCP
- Mallinckrodt
- Novacyl
- SKPL
- Strides Shasun
- Temad
- Anhui BBCA Likang
- Anhui Fubore
- Changshu Huagang
- Hebei Jiheng
- Xinhua Pharmaceutical
- Zhejiang Kangle
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Adult Antipyretics Market Size (2021-2032)
- 2.2.2 Global Adult Antipyretics Sales (2021-2032)
- 2.2.3 Global Adult Antipyretics Market Average Price (2021-2032)
- 2.3 Adult Antipyretics by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Acetaminophen
- 2.3.3 Ibuprofen
- 2.3.4 Other
- 2.4 Adult Antipyretics by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Online Sales
- 2.4.3 Offline Sales
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Adult Antipyretics Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Adult Antipyretics Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Adult Antipyretics Revenue of Manufacturers (2021-2026)
- 3.4 Global Adult Antipyretics Average Price by Manufacturers (2021-2026)
- 3.5 Global Adult Antipyretics Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Adult Antipyretics, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Adult Antipyretics, Product Type & Application
- 3.8 Global Manufacturers of Adult Antipyretics, Established Date
- 3.9 Global Adult Antipyretics Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Anqiu Lu'an
- 4.1.1 Anqiu Lu'an Company Information
- 4.1.2 Anqiu Lu'an Business Overview
- 4.1.3 Anqiu Lu'an Adult Antipyretics Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Anqiu Lu'an Adult Antipyretics Product Portfolio
- 4.1.5 Anqiu Lu'an Recent Developments
- 4.2 Atabay
- 4.2.1 Atabay Company Information
- 4.2.2 Atabay Business Overview
- 4.2.3 Atabay Adult Antipyretics Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Atabay Adult Antipyretics Product Portfolio
- 4.2.5 Atabay Recent Developments
- 4.3 Farmson
- 4.3.1 Farmson Company Information
- 4.3.2 Farmson Business Overview
- 4.3.3 Farmson Adult Antipyretics Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Farmson Adult Antipyretics Product Portfolio
- 4.3.5 Farmson Recent Developments
- 4.4 Granules Biocause
- 4.4.1 Granules Biocause Company Information
- 4.4.2 Granules Biocause Business Overview
- 4.4.3 Granules Biocause Adult Antipyretics Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Granules Biocause Adult Antipyretics Product Portfolio
- 4.4.5 Granules Biocause Recent Developments
- 4.5 Granules India
- 4.5.1 Granules India Company Information
- 4.5.2 Granules India Business Overview
- 4.5.3 Granules India Adult Antipyretics Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Granules India Adult Antipyretics Product Portfolio
- 4.5.5 Granules India Recent Developments
- 4.6 IOLCP
- 4.6.1 IOLCP Company Information
- 4.6.2 IOLCP Business Overview
- 4.6.3 IOLCP Adult Antipyretics Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 IOLCP Adult Antipyretics Product Portfolio
- 4.6.5 IOLCP Recent Developments
- 4.7 Mallinckrodt
- 4.7.1 Mallinckrodt Company Information
- 4.7.2 Mallinckrodt Business Overview
- 4.7.3 Mallinckrodt Adult Antipyretics Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Mallinckrodt Adult Antipyretics Product Portfolio
- 4.7.5 Mallinckrodt Recent Developments
- 4.8 Novacyl
- 4.8.1 Novacyl Company Information
- 4.8.2 Novacyl Business Overview
- 4.8.3 Novacyl Adult Antipyretics Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Novacyl Adult Antipyretics Product Portfolio
- 4.8.5 Novacyl Recent Developments
- 4.9 SKPL
- 4.9.1 SKPL Company Information
- 4.9.2 SKPL Business Overview
- 4.9.3 SKPL Adult Antipyretics Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 SKPL Adult Antipyretics Product Portfolio
- 4.9.5 SKPL Recent Developments
- 4.10 Strides Shasun
- 4.10.1 Strides Shasun Company Information
- 4.10.2 Strides Shasun Business Overview
- 4.10.3 Strides Shasun Adult Antipyretics Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Strides Shasun Adult Antipyretics Product Portfolio
- 4.10.5 Strides Shasun Recent Developments
- 4.11 Temad
- 4.11.1 Temad Company Information
- 4.11.2 Temad Business Overview
- 4.11.3 Temad Adult Antipyretics Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Temad Adult Antipyretics Product Portfolio
- 4.11.5 Temad Recent Developments
- 4.12 Anhui BBCA Likang
- 4.12.1 Anhui BBCA Likang Company Information
- 4.12.2 Anhui BBCA Likang Business Overview
- 4.12.3 Anhui BBCA Likang Adult Antipyretics Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Anhui BBCA Likang Adult Antipyretics Product Portfolio
- 4.12.5 Anhui BBCA Likang Recent Developments
- 4.13 Anhui Fubore
- 4.13.1 Anhui Fubore Company Information
- 4.13.2 Anhui Fubore Business Overview
- 4.13.3 Anhui Fubore Adult Antipyretics Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Anhui Fubore Adult Antipyretics Product Portfolio
- 4.13.5 Anhui Fubore Recent Developments
- 4.14 Changshu Huagang
- 4.14.1 Changshu Huagang Company Information
- 4.14.2 Changshu Huagang Business Overview
- 4.14.3 Changshu Huagang Adult Antipyretics Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Changshu Huagang Adult Antipyretics Product Portfolio
- 4.14.5 Changshu Huagang Recent Developments
- 4.15 Hebei Jiheng
- 4.15.1 Hebei Jiheng Company Information
- 4.15.2 Hebei Jiheng Business Overview
- 4.15.3 Hebei Jiheng Adult Antipyretics Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Hebei Jiheng Adult Antipyretics Product Portfolio
- 4.15.5 Hebei Jiheng Recent Developments
- 4.16 Xinhua Pharmaceutical
- 4.16.1 Xinhua Pharmaceutical Company Information
- 4.16.2 Xinhua Pharmaceutical Business Overview
- 4.16.3 Xinhua Pharmaceutical Adult Antipyretics Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Xinhua Pharmaceutical Adult Antipyretics Product Portfolio
- 4.16.5 Xinhua Pharmaceutical Recent Developments
- 4.17 Zhejiang Kangle
- 4.17.1 Zhejiang Kangle Company Information
- 4.17.2 Zhejiang Kangle Business Overview
- 4.17.3 Zhejiang Kangle Adult Antipyretics Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Zhejiang Kangle Adult Antipyretics Product Portfolio
- 4.17.5 Zhejiang Kangle Recent Developments
5 Global Adult Antipyretics Market Scenario by Region
- 5.1 Global Adult Antipyretics Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Adult Antipyretics Sales by Region: 2021-2032
- 5.2.1 Global Adult Antipyretics Sales by Region: 2021-2026
- 5.2.2 Global Adult Antipyretics Sales by Region: 2027-2032
- 5.3 Global Adult Antipyretics Revenue by Region: 2021-2032
- 5.3.1 Global Adult Antipyretics Revenue by Region: 2021-2026
- 5.3.2 Global Adult Antipyretics Revenue by Region: 2027-2032
- 5.4 North America Adult Antipyretics Market Facts & Figures by Country
- 5.4.1 North America Adult Antipyretics Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Adult Antipyretics Sales by Country (2021-2032)
- 5.4.3 North America Adult Antipyretics Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Adult Antipyretics Market Facts & Figures by Country
- 5.5.1 Europe Adult Antipyretics Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Adult Antipyretics Sales by Country (2021-2032)
- 5.5.3 Europe Adult Antipyretics Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Adult Antipyretics Market Facts & Figures by Country
- 5.6.1 Asia Pacific Adult Antipyretics Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Adult Antipyretics Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Adult Antipyretics Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Adult Antipyretics Market Facts & Figures by Country
- 5.7.1 South America Adult Antipyretics Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Adult Antipyretics Sales by Country (2021-2032)
- 5.7.3 South America Adult Antipyretics Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Adult Antipyretics Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Adult Antipyretics Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Adult Antipyretics Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Adult Antipyretics Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Adult Antipyretics Sales by Type (2021-2032)
- 6.1.1 Global Adult Antipyretics Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Adult Antipyretics Sales Market Share by Type (2021-2032)
- 6.2 Global Adult Antipyretics Revenue by Type (2021-2032)
- 6.2.1 Global Adult Antipyretics Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Adult Antipyretics Revenue Market Share by Type (2021-2032)
- 6.3 Global Adult Antipyretics Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Adult Antipyretics Sales by Application (2021-2032)
- 7.1.1 Global Adult Antipyretics Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Adult Antipyretics Sales Market Share by Application (2021-2032)
- 7.2 Global Adult Antipyretics Revenue by Application (2021-2032)
- 7.2.1 Global Adult Antipyretics Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Adult Antipyretics Revenue Market Share by Application (2021-2032)
- 7.3 Global Adult Antipyretics Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Adult Antipyretics Value Chain Analysis
- 8.1.1 Adult Antipyretics Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Adult Antipyretics Production Mode & Process
- 8.2 Adult Antipyretics Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Adult Antipyretics Distributors
- 8.2.3 Adult Antipyretics Customers
9 Global Adult Antipyretics Analyzing Market Dynamics
- 9.1 Adult Antipyretics Industry Trends
- 9.2 Adult Antipyretics Industry Drivers
- 9.3 Adult Antipyretics Industry Opportunities and Challenges
- 9.4 Adult Antipyretics Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst